Alan MacIntosh is listed as a director on 6 SEC Form D filings by 4 issuers between Jun 2014 and Apr 2018: Swift Medical Inc. (Toronto, Ontario, Canada (as filed: A6) — other health care — 2018; $17.5M reported sold to 5 investors), OMSignal Inc. (Montreal, Quebec, Canada (as filed: A8) — other technology — 2014–2015; $9.05M reported sold to 8 investors), ALGOLUX INC. (Montreal, Quebec, Canada (as filed: A8) — other technology — 2018; $9.01M reported sold to 7 investors) and Synbiota Inc. (Toronto, Ontario, Canada (as filed: A6) — other technology — 2014; $162K reported sold to 1 investors).
What this means A repeat sponsor — 4 separate companies raised money with this person listed as director, over about 4 years. Across those companies the filings report $35.7M sold in total.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 6 public filings for Alan MacIntosh and found 6 differences: Form D filed 54 days after the first sale; Form D filed 16 days after the first sale; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.